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Background: Crocus sativus, known as saffron crocus, is best known for the spice saffron. 
Saffron use spans more than 3500 years, however, its toxicity on neonates during lactation 
has not yet evaluated. 
Objectives: This study was aimed to examine the acute toxicity of  saffron on adult mice and its 
nephrotoxicity and hepatotoxicity on neonates of  lactating mothers that used saffron during 
lactation. 
Materials and Methods: In this experimental study, following acute toxicity evaluation, 32 
pregnant mice were randomly designated into four equal groups. Following delivery, the 
mothers of  groups 1 to 4 were administered orally (by gavage) normal saline (control group), 
500, 1000 or 2000 mg/kg/day of  saffron for three weeks, respectively. The newborns’ 
kidney and liver parameters were assessed at the end of  the study for possible nephrotoxicity 
and hepatotoxicity evaluation. The kidney and liver tissue samples of  newborns were 
histopathologically studied after staining with Hematoxylin & Eosin. Data were analyzed 
using ANOVA and Scheffe’s tests
Results: The LD50 value of  saffron was calculated to be 4120±556 mg/kg in mice. To evaluate 
lactating toxicity, saffron was administered orally to the mothers once daily for 21 days, after 
delivery, during lactating period. Saffron increased serum urea nitrogen (p< 0.05). Histological 
studies indicated that saffron did not have any toxic effect on liver, however, histopathology 
changes were seen in the kidney of  neonates. 
Conclusions: From the results of  present study, it might be concluded that saffron is a nearly 
safe spice, however, nursing mothers should avoid high doses of  this spice. 
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1. Introduction 
Medicinal plants have long been used or recently 
evaluated for different diseases, especially for 
hard curable conditions such as Alzheimer (1,2), 
atherosclerosis (3,4), diabetes mellitus (5,6), 
cancer (7,8) and gastrointestinal diseases (9,10).
Although these plants are considered to be safe, 
however, they may cause damage due to their 
unwanted side effects (11,12). Therefore, studying 
the side effects of  medicinal plants would have 
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heartburn, insomnia, hardening of  arteries, 
flatulence, Alzheimer’s disease, shock, hemoptysis, 
pain, alopecia, dry skin, as an aphrodisiac and 
expectorant (15).
The physiological action of  saffron is not well-
understood yet. Although saffron has been used 
for a long time in different countries with no 
reported clinical toxicity and seems to be safe, 
however, few investigations have been conducted 
on its toxicological profiles. Recently, in a clinical 
trial 1.2 g saffron petal induced diarrhea, bleeding, 
nausea and vomiting (16) and at 200 mg/kg/day 
changed some biochemical parameters in normal 
ranges, in healthy volunteers (17). 
2. Objectives
This study was aimed to evaluate the pathological 
effects of  different doses of  saffron on kidney 
and liver parameters in the newborns of  mice 
which their mothers were exposed to saffron 
during the lactating period.
3. Materials and Methods
In this experimental study saffron, prepared from 
Crocus sativus, was purchased from a grocery in 
Mashhad city in Khorasan province, Iran. The 
dried saffron was pulverized using mechanical 
mill and dissolved in hot water. For evaluation of 
acute toxicity (LD50), 32 Balb/C mice weighing 
30±2 g and aging about 12 weeks, purchased 
from Pasteur Institute of  Tehran were used. 
The animals were kept in laboratory animals in 
a normal condition with 21±2 oC temperature, 
and floor covering standards with unlimited 
water and food. To evaluate acute toxicity, 
animals were designated into 4 equal groups and 
were administrated by gavage 750, 1500, 3000 
and 6000 mg/kg doses of  saffron dissolved in 
distilled water. The animals were observed for 24 
hours for death status. For the first 8 hours their 
neurological symptoms were observed in two-
hour intervals. The mortality rate was measured 
and the LD50 was determined using Wilcoxon 
and Litchfield method (18). 
To evaluate the nephrotoxicity and hepatotoxicity Figure 1. Saffron, its flower and the Saffron crocus field
effective role in identifying and diagnosis of 
safety profile if  these drugs in human.
Crocus sativus, known as saffron crocus, is a 
flowering plant from Crocus genus (Iridaceae 
family) which is best known for the spice saffron, 
produced from its flowers (Figure 1). Saffron is 
one of  the world’s most costly spices (13). The 
cultivation of  Crocus sativus and saffron use spans 
more than 3,500 years. Crocus sativus grows up to 
about 12 inches and bears three to four flowers, 
each with three vivid crimson stigmas. The dried 
stigmas are used mainly as coloring agent. Crocus 
sativus was originated in Greece and is native to 
Southwest Asia especially Iran (13).
The saffron taste results from the chemicals 
safranal and picrocrocin. It also contains crocin 
which imparts a rich golden-yellow color 
to dishes (14). Nowadays, Iran accounts for 
about 90 % of  the world production and trade 
of  saffron. Saffron is widely used in Iranian, 
Indian, European, Turkish and Arab cuisines 
and confectioneries. Saffron substitutes include 
safflower Carthamus tinctorius (safflower) and 
Curcuma longa (turmeric) (13).
Saffron has many potential medicinal properties 
and a long history of  medicinal use as part of 
traditional healing. Recent research studies 
have suggested that saffron has preventive 
effects on cancer and cancer mutation. It has 
also immunomodulating, antioxidant and 
antidepressant activities. Saffron also protects 
the eyes from the direct effects of  bright light 
and retinal stress apart from slowing retinitis 
pigmentosa and macular degeneration. Male 
subjects use saffron for prevention of  premature 
ejaculation or infertility and women use it for 
premenstrual syndrome or menstrual cramps. 
Saffron is also used for cough, pertussis, asthma, 
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of  saffron in neonates of  lactating mothers, 32 
female Balb/C mice of  about 12 weeks old and 
weight range of  30±2 grams were employed. 
Each two female mice were placed in a cage with a 
male mouse for two nights for mating. Pregnancy 
was diagnosis by observing the vaginal plug and 
positive vaginal smear. Then the pregnant mice 
were randomly divided into three experimental 
and a control groups. 
Animal experiments were approved by the Ethical 
Committee of  Shahrekord University of  Medical 
Sciences, Iran. The animals were administered 
saline, 500, 1000 or 2000 mg/kg/day of  saffron 
from the delivery day until the end of  lactating 
period. A day after the last dose, cardiac blood 
sampling was collected, after making the animals 
anesthetized, in order to conduct biochemical 
studies. 
After blood sampling, the neonate mice were 
killed by cervical dislocation and their livers 
and kidneys were completely removed and 
fixed in 10% buffered formalin to determine 
pathology changes.
Sections of  3µ diameter were prepared after 
obtaining paraffin blocks and then were 
transferred to slides and were stained by 
Hematoxylin & Eosin stain. After confirming 
the normal distribution of  the data, they were 
analyzed by one-way ANOVA and in case of 
significant difference between the experimental 
and control groups, Scheffe’s test was used.  P< 
0.05 was considered as significantly different.
4. Results
4. 1. LD50 value evaluation 
Approximately 4 min following administration 
of  saffron, the animals became excited and 
exhibited hyperactivity which continued for not 
more than 5 min. Then the animals became 
sedated and their locomotor activities, food and 
water consumption decreased which were more 
significant at higher doses. The LD50 value of 
saffron in mice was calculated to be 4120±556 
mg/kg.
4.2. Effects of  saffron on neonates of  lactating mothers
Nephrotoxicity and hepatotoxicity effects of 
saffron in neonates of  lactating mothers were 
evaluated  following administration of  saffron 
(by gavage) for 21 days with 500, 1000 and 2000 
mg/kg/day. None of  these doses showed any 
significant difference in aspartate aminotransferase 
(AST), alanine aminotransferase (ALT), total 
bilirubin, serum creatinine and albumin (Table 1). 
The level of  serum urea nitrogen (BUN) in 1000 
and 2000 mg/kg/day dose groups of  animals 
decreased (Table 1).
4.3. Effect of  saffron on histopathological parameters of 
newborn mice
The histopathology examination of  the kidney 
and liver tissue sections of  newborn mice in the 
control group did not show any structural and 
pathological changes. The histopathology of 
neonates’ livers in the experimental group which 
their mothers received different doses of  saffron 
and the neonates’ kidneys which their mothers 
received lower dose of  saffron also revealed no 
structural changes.
In newborns of  the experimental group that 
received 1000 and 2000 mg/kg/day of  saffron, 
the histopathology study of  the kidney tissues 
showed interstitial nephritis accompanied by 
mononuclear inflammatory cell infiltration 
around the renal tubules, particularly around the 
renal arteries and the presence of  eosinophilic 
protein-rich fluid within renal tubules. In 
experimental groups which received 2000 mg/
kg/day dose, these observations were more 
pronounced and was along with presence of 
glomeruli disappearance in some areas of  the 
cortical region.
5. Discussion
The LD50 of  saffron in mice was calculated to 
be 4120±556 mg/kg. Based on the toxicity 
classifications, any substance with LD50 value 
within the range of  1 to 5 g/kg practically is usually 
considered as low-toxic and any substance with 
LD50 bellow 5 g/kg may be considered practically 
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non-toxic  (19,20). The calculated LD50 value of 
saffron in mice was in the range of  1-5 g/kg. 
Thus, saffron should practically be considered as 
low toxic in acute evaluation.
 Medicinal plants usually have various components 
which may possess potential of  causing useful 
and/or harmful effects. To evaluate beneficial 
effect of  saffron, other than assessing the acute 
and sub-acute toxicities, we need to assess its 
toxic effects in pregnancy and lactation, too. Due 
to variations in systems of  detoxification and 
differences in absorption, distribution, excretion 
mechanisms in different animal species, there are 
species differences in response to toxic substances 
(18). Therefore, the toxic effects in human should 
be considered with these differences.
In lactating toxicity study (three weeks evaluation), 
saffron at doses of  500, 1000 or 2000 mg/kg/day 
did not cause any death. However, animals which 
received saffron showed evidence of  hyperactivity 
and excitation which might be related to the 
irritant nature of  most essential oils. Following 
this excitation, saffron showed sedative effect 
and reduction of  loco  motor activity. Saffron 
has been shown to have an agonistic activity on 
GABAA receptors (21), hence, its hypnotic and 
anti-anxiety effects seem to be related to this 
interaction (22).
In this study, serum urea nitrogen was increased. 
Histopathology evaluations of  the kidney showed 
some changes and abnormalities. However, there 
were no changes on the histopathology and 
common markers of  liver toxicity such as ALT, 
AST and bilirubin. Thus, it might be presumed 
that saffron has no significant toxic effect to liver, 
but at high doses might cause kidney damage to 
Table 1. Effect of  different doses (mg/kg/day) of  saffron on serum biochemical parameters in mice treated for three weeks
Variable Parameter Saline Control 5000 1000 2000
BUN (mg/dL) 37.43 ± 3.2 35.16 ± 2.51 58.5 ± 4.99* 70.31 ± 13.30**
Creatinine(mg/dL) (mg/dL) 0.41 ± 0.03 0.44 ± 0.04 0.37 ± 0.02 0.37 ± 0.1
ALT (IU/L) 67.36 ± 7.01 71.21 ± 6.41 58.16 ± 3.04 68.03  ±  8.06
AST (IU/L) 87.66 ± 9 99.33 ± 7.94 117.5 ± 14.24 123.4 ± 40.15
ALP (IU/L) 63.05 ± 8.23 62.61 ± 5.52 55.3 ± 4.94 58,65 ± 4.06
Total bilirubin(mg/dL) (mg/dL) 0.42 ± 0.01 0.39 ± 0.02 0.39 ± 0.03 0.38 ± 0.03
Data are shown as Mean± SEM (n =8). *p < 0.05, **p < 0.01, compared with control group. BUN: blood urea nitrogen, 
ALT: alanine aminotransferase, AST: aspartate aminotransferase, and ALP: alkaline phosphatase.
the lactating neonates of  mothers that use saffron 
during lactation. 
The levels of  BUN and creatinine are appropriate 
indicators of  renal function. The animals treated 
with saffron showed an increase in blood urea 
nitrogen (BUN). The increased level of  BUN in 
the treated groups might be attributed to renal 
damage and this is further confirmed by the 
kidneys’ histopathology findings. 
6. Conclusions
In conclusion, from the results of  the present study 
on the acute and sub-acute toxicities of  saffron, 
it might be concluded that saffron prepared 
from Crocus sativus is a nearly safe spice, however, 
nursing mothers should avoid high doses of  this 
spice. The data suggest that administration of 
high doses of  saffron to mothers, in sub-acute 
evaluation might damage the infants’ kidneys. 
Further studies are necessary to evaluate more 
these results.
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